New findings presented at AAN 2022 have highlighted the changes in brain metabolism that occur in the presymptomatic phase of frontotemporal dementia (FTD) associated with mutations in the GRN gene.
The findings may offer a method for monitoring disease development in asymptomatic carriers before structural damage occurs.